🇺🇸 FDA
Patent

US 7122200

Vitro engineered, regenerated urinary tract tissue compositions and methods for producing same

granted A61KA61K35/12A61P

Quick answer

US patent 7122200 (Vitro engineered, regenerated urinary tract tissue compositions and methods for producing same) held by The Board of Regents of the University of Oklahoma expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K35/12, A61P, A61P43/00